MVRBF Stock UPDATES Medivir Ser B Sek5 (MVRBF) 18.5000 08/22/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medivir Ser B Sek5 (MVRBF) 18.5000 $MVRBF

Medivir names Niklas Prager as new President and CEO
M2 - Mon Aug 11, 7:27AM CDT
Medivir AB (STO:MVIRB.ST), a research-based pharmaceutical company, announced today the appointment of Niklas Prager as new president and CEO of Medivir AB, effective 1 September 2014.

Niklas Prager Appointed New President and CEO of Medivir
Business Wire - Mon Aug 11, 3:18AM CDT
Regulatory News:

Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim
Business Wire - Mon Aug 04, 1:38AM CDT
Regulatory News:

Medivir: Phase II COSMOS Study Results Published in The Lancet on World Hepatitis Day
Business Wire - Mon Jul 28, 1:41AM CDT
Regulatory News:

Medivir reports global net sales of USD831m for Olysio during Q2 2014
M2 - Wed Jul 16, 3:38AM CDT
Medivir AB (OMX:MVIR), a research-based pharmaceutical company focused on infectious diseases, announced on Tuesday that the global second quarter 2014 net sales of Olysio (simeprevir) amounted to USD831m, out of which USD725m were sales in the US.

Medivir: U.S. FDA Has Granted Priority Review for OLYSIO(R) in Combination with sofosbuvir Supplementary New Drug Application
Business Wire - Tue Jul 15, 8:41AM CDT
Medivir (STO:MVIR-B)

Medivir: Continued strong market uptake for OLYSIO(R) during the second quarter 2014
Business Wire - Tue Jul 15, 7:11AM CDT
Regulatory News:

Medivir's Simeprevir approved for treatment in Russia
M2 - Mon Mar 24, 5:26AM CDT
Medivir AB (STO:MVIRB.ST), a research-based pharmaceutical company focused on infectious diseases, announced today the approval by the Russian Ministry of Health of Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection in combination with pegylated interferon and ribavirin in HCV genotype 1 and 4 infected patients with compensated liver disease, including cirrhosis.

Medivir: New Simeprevir data will be presented at The International Liver Congress 2014 of the European Association for the Study of the Liver, (EASL)
Business Wire - Mon Mar 24, 4:48AM CDT
Regulatory News:

Medivir: Simeprevir has now been approved in Russia
Business Wire - Mon Mar 24, 2:40AM CDT
Regulatory News:

Medivir: The Nomination Committee's Proposal, with Reference to the Upcoming 2014 Annual General Meeting, for a New Board of Directors
Business Wire - Fri Mar 14, 7:43AM CDT
Regulatory News:

Medivir: SVR12 Results from a Phase IIa Study Evaluating Simeprevir and Daclatasvir in Hepatitis C Patients of Genotype 1 Have Been Presented
Business Wire - Tue Mar 04, 11:30AM CST
Regulatory News:

Medivir reports profit in 2013
M2 - Mon Feb 24, 6:37AM CST
Swedish medical research company Medivir AB (STO:MVIRB.ST) reported today profit after tax of SEK16m, or SEK 0.51 per share, for the year 2013, from 1 January 2013 to 31 December 2013.

Swedish Pharmaceutical Company Medivir AB Chooses Certara's D360 as Its Global Drug Discovery Platform
Business Wire - Mon Jan 27, 7:00AM CST
Certara(TM), a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected D360 as its global drug discovery platform. Certara's D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. Medivir will use D360 to deliver research data and analytic tools to its discovery chemists and biologists in Stockholm, Sweden, and Cambridge, UK. The information will be sourced from its existing repository of chemical structure and biological assay data.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 136

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 121

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 74

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 246

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 183

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading

Top 5 Most Recently Viewed Articles

Core Molding Technologies Set to Engage Investors at Roth

Updated Category News Views 111

Core Molding Technologies at Industry Conferences Core Molding Technologies, Inc. is excited to announce its upcoming participation in the prestigious Annual Roth Conference. This event is a fantastic opportunity for the management team to engage directly with investors and showcase the innovative solutions the company offers. Investors Meet Management During the...

Continue Reading
Minerals Technologies Announces Dividend for Shareholders

Updated Category News Views 174

Minerals Technologies Declares Quarterly Dividend Minerals Technologies Inc. (NYSE: MTX), a leading figure in the specialty minerals industry, has made an important announcement regarding its financial practices. The company has officially declared a regular quarterly dividend of $0.11 per share on its outstanding common stock. This decision reflects their commitment to...

Continue Reading
Converge Technology Solutions Recognized at Ingram Micro Summit

Updated Category News Views 104

Converge Technology Solutions Receives Prestigious Award Converge Technology Solutions Corp. (TSX: CTS) is excited to announce that the company has been named Solution Partner of the Year by Ingram Micro, a notable player in the global technology industry. The accolade comes during the recent Ingram Micro ONE Innovation Summit, highlighting Converge's exemplary...

Continue Reading
LONGi Solar's Strategic 102MW Partnership Elevates Nordic Energy

Updated Category News Views 174

LONGi Solar Partners for a Sustainable Future LONGi Solar has embarked on a significant journey by entering a strategic partnership with a prominent Finnish energy company. This collaboration centers on supplying 102MW of the advanced Hi-MO X10 back contact modules, marking a pivotal moment for LONGi as it enhances its footprint in the Nordic energy market. This agreement...

Continue Reading
Bascom Arizona Ventures Expands Portfolio with $53.4 Million Deal

Updated Category News Views 116

Bascom Arizona Ventures Acquires Multifamily Property Bascom Arizona Ventures, LLC (BAZV), an affiliate of a prominent private equity firm based in California, has successfully acquired the Retreat at Speedway, a multifamily property that features 304 units. The acquisition, valued at $53.4 million, translates to approximately $175,658 per unit. With this transaction,...

Continue Reading